William Blair Investment Management
AXDX

William Blair Investment Management’s Accelerate Diagnostics AXDX Stock Holding History

William Blair Investment Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-21,312
Closed -$4.42M – 436
2016
Q4 		$4.42M Sell
21,312
-3,401
-14% -$808K 0.02% 353
2016
Q3 		$6.74M Sell
24,713
-21,964
-47% -$4.86M 0.03% 337
2016
Q2 		$6.72M Sell
46,677
-444
-0.9% -$59.5K 0.03% 332
2016
Q1 		$6.77M Buy
47,121
+13,686
+41% +$1.93M 0.03% 328
2015
Q4 		$7.18M Buy
33,435
+15,036
+82% +$2.74M 0.03% 316
2015
Q3 		$2.98M Buy
+18,399
New +$3.98M 0.01% 839

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

William Blair Investment Management's AXDX Position: Q1 2017 in Review

William Blair Investment Management sold out of Accelerate Diagnostics (AXDX) in Q1 2017, closing a stake of 21,312 shares — an estimated $4.42M sold.

William Blair Investment Management first reported a position in AXDX in Q3 2015 and held it in 6 quarters. The position peaked at $7.18M in Q4 2015. 98 funds tracked by Wall St. Rank hold AXDX as of Q1 2017.

  • William Blair Investment Management reported no remaining Accelerate Diagnostics position as of Q1 2017 after selling out during the quarter.
  • William Blair Investment Management sold 21,312 Accelerate Diagnostics shares in Q1 2017, an estimated $4.42M.
  • William Blair Investment Management first reported a position in Accelerate Diagnostics in Q3 2015 and held it in 6 quarters.
  • William Blair Investment Management's Accelerate Diagnostics position peaked at $7.18M in Q4 2015.
  • 98 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2017.

Based on William Blair Investment Management's 13F filing for Q1 2017, filed 10 May 2017.